140 related articles for article (PubMed ID: 31776702)
1. Modified Gastric Cancer AJCC Staging with a Classification Based on the Ratio of Regional Lymph Node Involvement: A Population-Based Cohort Study.
Huang Z; Chen Y; Zhang W; Liu H; Wang Z; Zhang Y
Ann Surg Oncol; 2020 May; 27(5):1480-1487. PubMed ID: 31776702
[TBL] [Abstract][Full Text] [Related]
2. Proposal of a modified American Joint Committee on Cancer staging scheme for resectable pancreatic ductal adenocarcinoma with a lymph node ratio-based N classification: A retrospective cohort study.
Li HJ; Chen YT; Yuan SQ
Medicine (Baltimore); 2018 Aug; 97(34):e12094. PubMed ID: 30142869
[TBL] [Abstract][Full Text] [Related]
3. Equipping the 8th Edition American Joint Committee on Cancer Staging for Gastric Cancer with the 15-Node Minimum: a Population-Based Study Using Recursive Partitioning Analysis.
Yuan SQ; Chen YT; Huang ZP
J Gastrointest Surg; 2017 Oct; 21(10):1591-1598. PubMed ID: 28752402
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of the Number of Lymph Nodes Examined in Patients with Node-Negative Gastric Cancer.
Yang ZL; Zhu MH; Shi Q; Lu FM; Wang CX
J Gastrointest Surg; 2019 Mar; 23(3):460-467. PubMed ID: 30225793
[TBL] [Abstract][Full Text] [Related]
5. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of prognostic model based on extragastric lymph nodes metastasis and lymph node ratio in node-positive gastric cancer: a retrospective cohort study based on a multicenter database.
Zeng Y; Cai F; Wang P; Wang X; Liu Y; Zhang L; Zhang R; Chen L; Liang H; Ye Z; Deng J
Int J Surg; 2023 Apr; 109(4):794-804. PubMed ID: 36999785
[TBL] [Abstract][Full Text] [Related]
7. External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China.
Ye J; Ren Y; Wei Z; Hou X; Dai W; Cai S; Tan M; He Y; Yuan Y
Surg Oncol; 2018 Jun; 27(2):146-153. PubMed ID: 29937164
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
[TBL] [Abstract][Full Text] [Related]
9. Modified staging classification of gallbladder carcinoma on the basis of the 8
Wang J; Bo X; Shi X; Suo T; Xin Y; Nan L; Wang C; Ni X; Liu H; Pan H; Shen S; Li M; Lu P; Zhang D; Wang Z; Wang Y; Liu H
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):527-533. PubMed ID: 31630931
[TBL] [Abstract][Full Text] [Related]
10. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a Tumor-Ratio-Metastasis Staging System and the 8th AJCC TNM Staging System for Gastric Cancer.
Zhang M; Ding C; Xu L; Ou B; Feng S; Wang G; Wang W; Liang Y; Chen Y; Zhou Z; Qiu H
Front Oncol; 2021; 11():595421. PubMed ID: 34307116
[TBL] [Abstract][Full Text] [Related]
12. Number of positive nodes is superior to the lymph node ratio and American Joint Committee on Cancer N staging for the prognosis of surgically treated head and neck squamous cell carcinomas.
Roberts TJ; Colevas AD; Hara W; Holsinger FC; Oakley-Girvan I; Divi V
Cancer; 2016 May; 122(9):1388-97. PubMed ID: 26969807
[TBL] [Abstract][Full Text] [Related]
13. Anatomical location-based nodal staging system is superior to the 7th edition of the American Joint Committee on Cancer staging system among patients with surgically resected, histologically low-grade gastric cancer: A single institutional experience.
Chen MW; Chan CP; Lin YJ; Yen HH
PLoS One; 2019; 14(2):e0211836. PubMed ID: 30721261
[TBL] [Abstract][Full Text] [Related]
14. A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes.
Seeruttun SR; Xu L; Wang F; Yi X; Fang C; Liu Z; Wang W; Zhou Z
Cancer Commun (Lond); 2019 Jun; 39(1):32. PubMed ID: 31182160
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database.
Wang J; Dang P; Raut CP; Pandalai PK; Maduekwe UN; Rattner DW; Lauwers GY; Yoon SS
Ann Surg; 2012 Mar; 255(3):478-85. PubMed ID: 22330040
[TBL] [Abstract][Full Text] [Related]
16. Lymph node ratio-based staging system for esophageal squamous cell carcinoma.
Chen SB; Weng HR; Wang G; Zou XF; Liu DT; Chen YP; Zhang H
World J Gastroenterol; 2015 Jun; 21(24):7514-21. PubMed ID: 26139998
[TBL] [Abstract][Full Text] [Related]
17. Proposed Modification of the 8th Edition of the AJCC Staging System for Gastric Cancer.
Jiang Y; Tu R; Lu J; Zhang Y; Zhu J; Tang W; Gu M; Huang C; Gu X
J Invest Surg; 2020 Dec; 33(10):932-938. PubMed ID: 30885025
[No Abstract] [Full Text] [Related]
18. The lymph node ratio as a prognostic factor for gastric cancer.
Nelen SD; van Steenbergen LN; Dassen AE; van der Wurff AA; Lemmens VE; Bosscha K
Acta Oncol; 2013 Nov; 52(8):1751-9. PubMed ID: 23317142
[TBL] [Abstract][Full Text] [Related]
19. The 8th edition American Joint Committee on gastric cancer pathological staging classification performs well in a population with high proportion of locally advanced disease.
Huang SF; Chien TH; Fang WL; Wang F; Tsai CY; Hsu JT; Yeh CN; Chen TC; Wu RC; Chiu CT; Yeh TS
Eur J Surg Oncol; 2018 Oct; 44(10):1634-1639. PubMed ID: 29941227
[TBL] [Abstract][Full Text] [Related]
20. Modified ypTNM Staging Classification for Gastric Cancer after Neoadjuvant Therapy: A Multi-Institutional Study.
Zhong Q; Chen QY; Parisi A; Ma YB; Lin GT; Desiderio J; Yan S; Xie JW; Wang JB; Hou JF; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Liu ZY; Que SJ; Li P; Zheng CH; Huang CM
Oncologist; 2021 Jan; 26(1):e99-e110. PubMed ID: 32864840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
